Patents by Inventor Mark B. Roth

Mark B. Roth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS REGARDING POLYCHALCOGENIDE COMPOSITIONS
    Publication number: 20080318864
    Abstract: The present invention concerns the use of polychalcogenide compositions on cells, tissue, organs, and organisms to enhance their survivability. It includes compositions, compounds, methods, articles of manufacture and apparatuses for enhancing survivability and for protecting them from or treating them for injury or damage. In specific embodiments, there are also therapeutic methods and apparatuses for hypoxic/ischemic injury, organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the polychalcogenide compositions described.
    Type: Application
    Filed: June 25, 2008
    Publication date: December 25, 2008
    Applicant: Fred Hutchinson Cancer Research Center
    Inventors: Mark B. Roth, Mike Morrison
  • Methods, Compositions and Articles of Manufacture for Treating Shock and Other Adverse Conditions
    Publication number: 20080226750
    Abstract: The present invention concerns the use of active compounds for inducing apnea and treating shock, in addition to enhancing the survivability of a subject. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving these effects.
    Type: Application
    Filed: April 20, 2007
    Publication date: September 18, 2008
    Inventors: Mark B. Roth, Mike Morrison
  • Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms
    Publication number: 20080171725
    Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 17, 2008
    Inventors: Mark B. Roth, Mike Morrison, Eric Blackstone, Dana Miller
  • Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms
    Publication number: 20080171093
    Abstract: The present invention concerns the use of oxygen antagonists for inducing stasis in cells, tissues, and/or organs in vivo or in an organism overall. It includes methods and apparatuses for achieving stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer is provided.
    Type: Application
    Filed: August 12, 2007
    Publication date: July 17, 2008
    Applicant: Fred Hutchinson Cancer Research Center, Inc.
    Inventors: Mark B. Roth, Eric Blackstone
  • Methods, Compositions and Articles of Manufacture for Enhancing Survivability of Cells, Tissues, Organs, and Organisms
    Publication number: 20080171726
    Abstract: The present invention concerns the use of oxygen antagonists and other active compounds for inducing stasis or pre-stasis in cells, tissues, and/or organs in vivo or in an organism overall, in addition to enhancing their survivability. It includes compositions, methods, articles of manufacture and apparatuses for enhancing survivability and for achieving stasis or pre-stasis in any of these biological materials, so as to preserve and/or protect them. In specific embodiments, there are also therapeutic methods and apparatuses for organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer using the active compounds described.
    Type: Application
    Filed: August 12, 2007
    Publication date: July 17, 2008
    Inventors: Mark B. Roth, Mike Morrison, Eric Blackstone, Dana Miller
  • DNA vaccine against feline immunodeficiency virus
    Publication number: 20040102411
    Abstract: The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.
    Type: Application
    Filed: September 26, 2003
    Publication date: May 27, 2004
    Inventors: Ruitang Deng, Eric D. Fuog, Suresh Jeevarathnam, Anthony F. Johnson, William D. Koertje, Mark B. Roth, Michael G. Shepperd, David W. Wheeler, Terecita D. Yule
  • DNA vaccine against feline immunodeficiency virus
    Publication number: 20040076632
    Abstract: The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.
    Type: Application
    Filed: September 26, 2003
    Publication date: April 22, 2004
    Inventors: Ruitang Deng, Mark B. Roth, Michael G. Shepperd, David W. Wheeler, Terecita D. Yule, Eric D. Fuog, Suresh Jeevarathnam, Anthony F. Johnson, William D. Koertje
  • DNA vaccine against feline immunodeficiency virus
    Publication number: 20040047878
    Abstract: The present invention is directed to vaccine compositions that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine components against feline immunodeficiency virus.
    Type: Application
    Filed: September 26, 2003
    Publication date: March 11, 2004
    Inventors: Ruitang Deng, Mark B. Roth, Michael G. Shepperd, David W. Wheeler, Terecita D. Yule, Eric D. Fuog, Suresh Jeevarathnam, Anthony F. Johnson, William D. Koertje